TorontoStarts

Investor

B Capital Group

VC firm

Key details

Profile type
Organization
Geography
Unknown / Other
Stage
3. Early Revenue
Sector
in vitro diagnostics, CBD, metabolites, therapeutic, pharma, metabolomics, digital-health, genomics, therapeutics, mental health, gene therapy, life sciences tools, fintechs, wellness, tech-enabled health, healthcare, financial services, finance, wellbeing, fin-tech, CGT, B2B2C, telehealth, lifesciences, biopharma, connected-health, lifescience, cell therapy, ehealth, life science, consumer, lending, mRNA, fintech, longevity, well-being, insurtech, psychedelics, biotech, banking, psychedelic, wealthtech, B2C, life-science, regtech, insurtechs, healthier living, transcriptomics, bio, pharmaceuticals, b-to-c, payment, paytech, health, IVD, drug, healthtech, insur tech, biomarkers, e-health, proteomics, finserv, bank, protein, life sciences, insuretech, drugs, cannabis, connected health, insurance, medicines, health-tech
Invests in
["USA","Israel","Canada","Singapore"]
Investment size
N/A
Founder groups
Not publicly stated

Official source

TorontoStarts does not endorse or rank this record. Confirm current details with the official source.

Check current details

Related records

Investor

10X Capital

VC firm

Geography
New York City, New York, USA
Stage / audience
2. Prototype, 3. Early Revenue, 4. Scaling, 5. Growth, 6. Pre-IPO
View profile